Request more information
Request more information

The use of shock wave therapy is contraindicated and constitutes an exclusion criterion for patients in the following cases:

  • Air-filled tissues (such as the lungs, trachea, and hollow cavities) cannot be treated.
  • Tendons with pre-existing Grade II or Grade III tears cannot be treated.
  • Pregnant women cannot undergo shock wave therapy.
  • Patients under the age of 18 cannot be treated (except for indications such as Osgood-Schlatter disease and spasticity treatments, with due caution regarding the potential risk to immature growth plates).
  • Patients with severe blood coagulation disorders (including local thrombosis) cannot be treated.
  • Treatment of tissues affected by tumors (cancer) is contraindicated.
  • Anatomical areas that have received local corticosteroid injections within the previous 4 to 6 weeks cannot be treated.
  • Areas involving the ears or the ear itself cannot be treated due to the serious risk of adverse effects.
  • Areas involving the eyes, eye cavity, or eyelids cannot be treated due to the serious risk of adverse effects.
  • Infections at the treatment site.
  • High blood pressure.

For urology applications, the following contraindications should be taken into account:

  • Bacterial prostatitis.
  • Penile prosthesis.
  • Hypogonadism.
  • Neurological diseases (e.g. multiple sclerosis, neurological brain disorders).
  • Psychiatric disorders (e.g. bipolar disorder/chronic depression).
  • Alcohol/drug abuse.

For dermatology applications, the following contraindications should be taken into account:

  • Infectious lesions (Wagner-Armstrong Grade B and D).
  • Necrotic lesions (Wagner-Armstrong Grade 4–5).
  • Thrombosis in the treated area.
  • Large blood vessels in the treated area.
  • Cartilaginous tissue during the growth phase.

General side effects:

The following side effects usually resolve relatively quickly (within 1 to 2 weeks).

Possible side effects associated with this treatment include:

  • Petechiae.
  • Skin irritation and redness.
  • Hematoma and edema.
  • Inflammation and numbness of the skin in the treated area.
  • Pain and discomfort during and after treatment at the application site (anesthesia is not required).

There is a possibility of brief hematospermia (blood in semen), hematuria (reddish-colored urine), acute bacterial prostatitis, urinary tract infection, urinary retention (due to possible prostate swelling), or a temporary increase in PSA (prostate-specific antigen) levels.

It is important to pay attention to and detect early symptoms and warning signs should they occur, and to discontinue treatment if necessary. Only when shock waves are not applied correctly may they cause:

  • Potential damage to lung tissue, intestines, trachea, ears, and eyes.
  • Potential damage to ruptured tendons.
  • Potential damage to immature growth plates.
  • Potential dissemination of malignant tumors.
  • Potential damage to articular cartilage.
  • Skin lesions may occur in patients who have previously undergone prolonged corticosteroid treatment.
  • Paresthesia and hypoesthesia in the treated area and in distal areas related to the treated region.
  • Vasovagal syndrome: symptoms may include dizziness, cold sweating, general discomfort, nausea, hypotension, and in some cases syncope with loss of consciousness. This should be taken into consideration, particularly in high-energy applications.
  • Tinnitus, ringing in the ears, and other serious hearing damage may occur due to the impact of shock waves on the ear. The application of shock waves to the ear is strictly prohibited.
  • Severe ocular damage may occur due to the impact of shock waves on the eye cavity. The application of shock waves to the orbital cavities of the eyes is strictly prohibited.

Before resuming treatment, ensure that all side effects have completely resolved.

The responsible practitioner must decide whether the planned treatment is appropriate, taking into account the patient’s overall health condition. CORR MEDICAL S.L., distributor of shock wave emission devices, shall not be held liable for direct or indirect damages resulting from improper use or handling of the distributed products, particularly due to failure to follow the operating instructions or inadequate preparation and maintenance.

Before using shock wave equipment, please read, understand, and carefully follow the recommendations provided in the instruction manual. Failure to comply with these operating instructions may result in injury to the patient or user, or damage to the product. The products may only be used by qualified personnel for their intended purpose and for the applications described in the manual. During installation, Corr Medical provides all clients with printed and electronic PDF copies in Spanish of the operating manuals for all supplied products.